Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 13/20 | 0.37 |
| ▸ | CNR2 | P34972 | 10/20 | 0.37 |
| ▸ | LDHA | P00338 | 2/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.36 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.36 |
| ▸ | GPR183 | P32249 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22860894 | 0.87 | DAGLA (0.39) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL29661414 | 0.87 | CNR1 (0.43) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL22860842 | 0.87 | CNR1 (0.43) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL22860965 | 0.85 | CNR1 (0.41) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL29661416 | 0.85 | CNR1 (0.41) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL29661422 | 0.85 | DAGLA (0.38) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL22860856 | 0.85 | DAGLA (0.38) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL29661411 | 0.83 | NAAA (0.58) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL22860871 | 0.82 | NAAA (0.41) | DAGLANAAACNR1CNR2LDHA | |
| SCHEMBL22860817 | 0.82 | DAGLA (0.40) | DAGLANAAACNR1CNR2LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3994129-A1 | CANNABINOID DERIVATIVES | Canopy Growth Corporation (CA) | 2022-05-11 | — | — | EP | claimed |
| US-20220242844-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2022-08-04 | — | — | US | disclosed |
| EP-3994129-A1 | CANNABINOID DERIVATIVES | Canopy Growth Corporation (CA) | 2022-05-11 | — | — | EP | disclosed |
| WO-2021000054-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2021-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220242844-A1 | CANNABINOID DERIVATIVES | CNR2, CNR1, FAAH | DAGLA 214/4885NAAA 156/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.